Open main menu

Wikipedia β

Ibrahim Abouleish (23 March 1937 – 15 June 2017)[1] began his chemistry and medicine studies at the age of 19 in Austria. He did his doctorate in 1969 in the field of pharmacology and then worked in leading positions within pharmaceutical research. During this time he was granted patents for a number of new medicines, especially for osteoporosis and arteriosclerosis.[citation needed]

Ibrahim Abouleish
Ibrahim Anouleish 20071120 1.jpg
Born (1937-03-23)23 March 1937
Mashtul, Egypt
Died 15 June 2017(2017-06-15) (aged 80)
Egypt
Nationality Egyptian
Occupation Pharmaceutical
Known for SEKEM

In 1977 he returned to Egypt and founded the comprehensive development initiative SEKEM. The organization focuses on biodynamic farming methods in Egypt.

In 2003, Ibrahim Abouleish and SEKEM received the Right Livelihood Award for integrating the commercial success with promotion of the social and cultural development of society. He was selected as an "Outstanding Social Entrepreneur" by the Schwab Foundation in 2004.[2] In 2006 he was appointed as a councillor at the World Future Council.[3] In 2012, Dr. Ibrahim Abouleish was appointed an Oslo Business for Peace Honouree, receiving his award at Oslo City Hall, from The Business for Peace Foundation. In 2013 he received the Global Thinkers Forum 2013 Award for Excellence in Positive Change.

ReferencesEdit

External linksEdit